Generation of cardio-protective antibodies after pneumococcal polysaccharide vaccine: Early results from a randomised controlled trial.
Sign Up to like & getrecommendations! Published in 2022 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2022.02.011
Abstract: BACKGROUND AND AIMS Observational studies have demonstrated that the pneumococcal polysaccharide vaccine (PPV) is associated with reduced risk of cardiovascular events. This may be mediated through IgM antibodies to OxLDL, which have previously been associated… read more here.
Keywords: controlled trial; pneumococcal polysaccharide; polysaccharide vaccine; anti oxldl ... See more keywords
Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery.
Sign Up to like & getrecommendations! Published in 2017 at "Vaccine"
DOI: 10.1016/j.vaccine.2016.12.065
Abstract: OBJECTIVES Pneumococcal vaccination is recommended to lower the risk of posttraumatic meningitis, and early vaccination may be of importance. After both trauma and central nervous system injury, immune-suppression may occur, which could affect T-cell function… read more here.
Keywords: neurotrauma neurosurgery; administered early; pneumococcal polysaccharide; early neurotrauma ... See more keywords
Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.04.017
Abstract: BACKGROUND While herd effects and serotype replacement by childhood pneumococcal protein conjugated vaccines (PCVs) continues to accumulate worldwide, direct effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal diseases in the elderly has been challenged.… read more here.
Keywords: polysaccharide vaccine; direct effectiveness; pneumococcal polysaccharide; ipd ... See more keywords
[Effectiveness of 23-valent pneumococcal polysaccharide vaccine on adult pneumococcal disease].
Sign Up to like & getrecommendations! Published in 2020 at "Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]"
DOI: 10.3760/cma.j.cn112150-20191107-00845
Abstract: Streptococcus pneumoniae (Spn) will cause various pneumococcal diseases when host has a weak immune system. The World Health Organization ranks it as one of the 12 key pathogens causing heavy burden of disease. At present,… read more here.
Keywords: adult; disease; pneumococcal polysaccharide; pneumococcal diseases ... See more keywords